Executive Summary
1 Market Overview
1.1 Global Human Microbiome Therapeutics Market
1.1.1 Overview
1.1.2 Global Market Scenario
1.1.3 Market Dynamics
1.2 Product Mapping

2 Scope of the Work
2.1 Overview: Report Scope
2.2 Segmentation of the Global Human Microbiome Therapeutics Market
2.3 Assumptions and Limitations
2.4 Key Questions Answered in the Report
2.5 Base Year and Forecast Period

3 Research Methodology
3.1 Overview: Report Methodology

4 Industry Analysis
4.1 Regulatory Scenario
4.2 Regulatory Designations
4.3 Regulatory requirements for Live Biotherapeutic Products (LBPs)
4.4 Patent Analysis

5 Competitive Landscape
5.1 Overview
5.2 Key Developments and Strategies
5.2.1 Collaborations and Partnerships
5.2.2 Mergers and Acquisitions
5.2.3 Business Expansions
5.3 Market Share Analysis
5.4 Funding Scenario
5.5 Government Initiatives

6 Global Human Microbiome Therapeutics Market (by Development Phase)
6.1 Overview
6.2 Commercialized Drugs
6.3 Drugs in Phase 4
6.4 Drugs in Phase 3

7 Global Human Microbiome Therapeutics Market (by Indication)
7.1 Overview
7.2 Gastrointestinal and Infectious Diseases
7.3 Oncology and Autoimmune Diseases
7.4 Skin Diseases
7.5 Others

8 Global Human Microbiome Therapeutics Market (by Region)
8.1 Overview
8.2 North America
8.2.1 Overview
8.2.2 U.S.
8.2.3 Canada
8.3 Europe
8.3.1 Overview
8.3.2 France
8.3.3 Sweden
8.3.4 Germany
8.3.5 U.K.
8.3.6 Rest-of-Europe
8.4 Asia-Pacific
8.4.1 Overview
8.4.2 Japan
8.4.3 Australia
8.4.4 China
8.4.5 India
8.4.6 Rest-of-Asia-Pacific
8.5 Rest-of-the-World
8.5.1 Overview
8.5.2 Middle East and Africa
8.5.3 Latin America

9 Company Profiles
9.1 Overview
9.2 4D Pharma plc
9.2.1 Company Overview
9.2.2 Role of 4D Pharma plc in the Global Human Microbiome Therapeutics Market
9.2.3 Financials
9.2.4 SWOT Analysis
9.3 AOBiome
9.3.1 Company Overview
9.3.2 Role of AOBiome in the Global Human Microbiome Therapeutics Market
9.3.3 SWOT Analysis
9.4 Finch Therapeutics
9.4.1 Company Overview
9.4.2 Role of Finch Therapeutics in the Global Human Microbiome Therapeutics Market
9.4.3 SWOT Analysis
9.5 Ferring Pharmaceuticals
9.5.1 Company Overview
9.5.2 Rebiotix Inc. (Subsidiary of Ferring Pharmaceuticals): Company Overview
9.5.3 Role of Rebiotix Inc. in the Global Human Microbiome Therapeutics Market
9.5.4 SWOT Analysis
9.6 Immuron Limited
9.6.1 Company Overview
9.6.2 Role of Immuron in the Global Human Microbiome Therapeutics Market
9.6.3 Financials
9.6.4 SWOT Analysis
9.7 MaaT Pharma
9.7.1 Company Overview
9.7.2 Role of MaaT Pharma in the Global Human Microbiome Therapeutics Market
9.7.3 SWOT Analysis
9.8 Naked Biome
9.8.1 Company Overview
9.8.2 Role of Naked Biome in Human Microbiome Therapeutics Market
9.8.3 SWOT Analysis
9.9 OxThera AB
9.9.1 Company Overview
9.9.2 Role of OxThera AB in the Global Human Microbiome Therapeutics Market
9.9.3 SWOT Analysis
9.10 Quorum Innovations
9.10.1 Company Overview
9.10.2 Role of Quorum Innovations, LLC in Human Microbiome Therapeutics Market
9.10.3 SWOT Analysis
9.11 Ritter Pharmaceuticals
9.11.1 Company Overview
9.11.2 Role of Ritter Pharmaceuticals in the Global Human Microbiome Therapeutics Market
9.11.3 Financials
9.11.4 SWOT Analysis
9.12 Sanofi S.A.
9.12.1 Company Overview
9.12.2 Role of Sanofi S.A. in the Global Human Microbiome Therapeutics Market
9.12.3 Financials
9.12.3.1 Key Insights About the Financial Health of the Company
9.12.4 SWOT Analysis
9.13 Seres Therapeutics, Inc.
9.13.1 Company Overview
9.13.2 Role of Seres Therapeutics, Inc. in the Global Human Microbiome Therapeutics Market
9.13.3 Financials
9.13.3.1 Key Insights About Financial Health of the Company
9.13.4 SWOT Analysis
9.14 Synthetic Biologics, Inc.
9.14.1 Company Overview
9.14.2 Role of Synthetic Biologics, Inc. in the Global Human Microbiome Therapeutics Market
9.14.3 Financials
9.14.4 SWOT Analysis
9.15 Taisho Pharmaceutical
9.15.1 Company Overview
9.15.2 Biofermin Pharmaceutical Co. Ltd. (Subsidiary of Taisho Pharmaceutical) Company Overview
9.15.3 Role of Taisho Pharmaceutical in Global Human Microbiome Therapeutics Market
9.15.4 Financial
9.15.4.1 Key Insights about the Financial Health of the Company
9.15.5 SWOT Analysis
9.16 Vedanta Biosciences, Inc.
9.16.1 Company Overview
9.16.2 Role of Vedanta Biosciences, Inc. in the Global Human Microbiome Therapeutics Market
9.16.3 SWOT Analysis
9.17 Whole Biome Inc.
9.17.1 Company Overview
9.17.2 Role of Whole Biome Inc. in the Global Human Microbiome Therapeutics Market
9.17.3 SWOT Analysis